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Sources of Prescription Opioid Pain Relievers by Frequency of 
Past-Year Nonmedical Use: United States, 2008-2011
Christopher M. Jones, PharmD, MPH, Leonard J. Paulozzi, MD, MPH, Karin A. Mack, PhD
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 
Atlanta, Georgia.
The health consequences of nonmedical use of prescription opioid pain relievers, such as 
oxycodone and hydrocodone, are significant.1 The commonly cited statistic that most 
nonmedical users obtain these medications from friends or family for free2 often serves as 
the basis for interventions focused onpatients. This statistic, however, reflects sources among 
all nonmedical users, from those who used the drug once or twice to more frequent users. 
Recent research indicates that frequent nonmedical users are increasing in numbers and 
differ from infrequent users with respect to high-risk behaviors.3,4 Little research has 
examined whether the source of opioid medication differs by frequency of nonmedical use. 
Such research can inform the development of appropriately targeted interventions.
Methods ∣
We obtained our data from the National Survey on Drug Use and Health (NSDUH), an 
annual survey of the non-institutionalized, civilian population 12 years or older that provides 
estimates of substance use in the United States.2 We combined NSDUH public use files5 for 
the years 2008 through 2011 to improve the precision of estimates. Institutional review 
board approval and informed consent were not needed because this was a secondary analysis 
of data from a public use file.
Respondents were asked about classes of drugs prone to abuse. They were told that 
questions about pain relievers applied to prescription opioids and selected barbiturate 
combination products. Nonmedical use was defined as use without a prescription or use with 
a prescription for the feeling or the experience caused by the drug. Respondents reported the 
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frequency of nonmedical use, the type of opioid pain reliever used, and the source of the 
opioid used most recently.
We categorized the frequency of nonmedical use into the following 4 groups: 1 to 29,30 to 
99,100 to 199, and 200 to 365 days. This categorization has been used previously to examine 
trends in the frequency of nonmedical use of pain relievers.4 The sources of opioid pain 
relievers were categorized into the following 6 groups: given by a friend or a relative for 
free, prescribed by 1 or more physicians, stolen from a friend or a relative, bought from a 
friend or a relative, bought from a drug dealer or other stranger, and other source. Average 
annual estimates for 2008 through 2011 were produced using proprietary software for 
interpretation of the survey results (SPSS Complex Samples; IBM) to account for the 
NSDUH’s sampling methods and weighting. We used 2-tailed t tests for statistical testing.
Results ∣
We identified an average annual estimated 12 007 202 past-year nonmedical users 12 years 
or older; of these, 11 018 735 (91.8%) reported a source of an opioid pain reliever. Most 
nonmedical users were men, and more than half had annual incomes of less than $50 000 
(Table 1). Most nonmedical users obtained opioid pain relievers from friends and relatives 
for free (Table 2); however, the source varied significantly by frequency of nonmedical use. 
Opioid pain relievers were obtained from a friend or a relative for free with decreasing 
frequency (from 61.9% to 26.4%) as the reported days of nonmedical use increased from a 
range of 1 to 29 to a range of 200 to 365. Opioid pain relievers were obtained from other 
sources, including prescriptions from physicians and purchases from a friend or a relative or 
from a drug dealer or a stranger, with greater frequency as the reported days of non-medical 
use increased. Among nonmedical users reporting 200 to 365 days of use, opioid pain 
relievers were most often obtained via prescription from physicians (27.3%).
Discussion ∣
The overall distribution of sources for opioids used for nonmedical purposes largely reflects 
the behavior of the lowest-use, lowest-risk group (1-29 days), which accounts for 63.9% of 
the sample. However, the highest-use, highest-risk group (200-365 days) reports different 
sources. This group is more likely than those with the lowest frequency of use to obtain 
opioids from a physician’s prescription or from a drug dealer. This pattern is similar to that 
of patients in opioid treatment programs, who cite dealers and physicians as frequent 
sources.6
These results underscore the need for interventions targeting prescribing behaviors, in 
addition to those targeting medication sharing, selling, and diversion. The essential steps 
healthcare providers cantake to curb this serious health problem include more judicious 
prescribing, use of prescription drug-monitoring programs, and screening patients for abuse 
risk before prescribing opioids.
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Table 1.
Characteristics of People 12 Years or Older Reporting Past-Year Nonmedical Use and Source of Most 
Recently Used Opioid Pain Relievera
Users, No. (%)b
Demographic Characteristic Unweighted Weighted
Sex
 Male 7784 (51.7) 6 119 200 (55.5)
 Female 7264 (48.3) 4 899 535 (44.5)
Age group, y
 12-17 3908 (26.0) 1 278 018 (11.6)
 18-25 7958 (52.9) 3 537 032 (32.1)
 26-34 1585 (10.5) 2 472 437 (22.4)
 35-49 1257 (8.4) 2 404 759 (21.8)
 ≥50 340 (2.3) 1 326 489 (12.0)
Race
 White (non-Hispanic) 10420 (69.2) 8 104 148 (73.5)
 Hispanic 1997 (13.3) 1 372 240 (12.5)
 African American (non-Hispanic) 1380 (9.2) 979 761 (8.9)
 Other 1251 (8.3) 562 586 (5.1)
Total annual family income, $c
 <20000 4196 (27.9) 2 616 194 (23.7)
 20000-49999 5296 (35.2) 3 839 034 (34.8)
 50000-74 999 2292 (15.2) 1 739 543 (15.8)
 ≥75 000 3264 (21.7) 2 823 965 (25.6)
Rural/urban status
 Large metropolitan county 6195 (41.2) 5 678 591 (51.5)
 Small metropolitan county 5706 (37.9) 3 676 570 (33.4)
 Nonmetropolitan county 3147 (20.9) 1 663 574 (15.1)
Total 15 048 (100.0) 11 018 735 (100.0)
aObtained from the US National Survey on Drug Use and Health, 2008 through 2011.5
b
Percentages have been rounded and may not sum to 100.
cWeighted numbers have been rounded.
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